Wolverine Trading
CMD

Wolverine Trading’s Cantel Medical Corporation CMD Stock Holding History

Wolverine Trading’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,100
Closed -$444K – 5438
2020
Q2 		$444K Buy
10,100
+4,000
+66% +$149K ﹤0.01% 2870
2020
Q1 		$232K Buy
+6,100
New +$347K ﹤0.01% 3514
2019
Q4 		– Sell
-2,900
Closed -$218K – 5460
2019
Q3 		$218K Sell
2,900
-3,200
-52% -$271K ﹤0.01% 3487
2019
Q2 		$492K Buy
+6,100
New +$429K ﹤0.01% 2740
2018
Q3 		– Sell
-2,900
Closed -$323K – 6243
2018
Q2 		$323K Hold
2,900
– – ﹤0.01% 3671
2018
Q1 		$323K Buy
+2,900
New +$325K ﹤0.01% 3671
2017
Q3 		– Sell
-6,900
Closed -$532K – 5295
2017
Q2 		$532K Buy
+6,900
New +$518K ﹤0.01% 2370
2016
Q4 		– Sell
-3,700
Closed -$286K – 5432
2016
Q3 		$286K Buy
+3,700
New +$268K ﹤0.01% 3307

Wolverine Trading's CMD Position: Q2 2019 in Review

Wolverine Trading sold out of Cantel Medical Corporation (CMD) in Q2 2019, closing a stake of 5,694 shares — an estimated $400K sold.

Wolverine Trading first reported a position in CMD in Q4 2016 and held it in 3 quarters. The position peaked at $416K in Q3 2017. 242 funds tracked by Wall St. Rank hold CMD as of Q2 2019.

  • Wolverine Trading reported no remaining Cantel Medical Corporation position as of Q2 2019 after selling out during the quarter.
  • Wolverine Trading sold 5,694 Cantel Medical Corporation shares in Q2 2019, an estimated $400K.
  • Wolverine Trading first reported a position in Cantel Medical Corporation in Q4 2016 and held it in 3 quarters.
  • Wolverine Trading's Cantel Medical Corporation position peaked at $416K in Q3 2017.
  • 242 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2019.

Based on Wolverine Trading's 13F filing for Q2 2019, filed 20 Aug 2019.